Abacus Planning Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03M Buy
2,527
+58
+2% +$59.3K 0.37% 36
2026
Q1
$2.27M Sell
2,469
-126
-5% -$128K 0.31% 44
2025
Q4
$2.79M Buy
2,595
+116
+5% +$111K 0.37% 38
2025
Q3
$1.89M Buy
2,479
+48
+2% +$35.7K 0.26% 54
2025
Q2
$1.9M Sell
2,431
-57
-2% -$44.3K 0.28% 50
2025
Q1
$2.06M Buy
2,488
+79
+3% +$65.7K 0.36% 40
2024
Q4
$1.86M Buy
2,409
+43
+2% +$35.6K 0.33% 42
2024
Q3
$2.1M Sell
2,366
-107
-4% -$96.2K 0.37% 38
2024
Q2
$2.24M Buy
2,473
+596
+32% +$477K 0.43% 32
2024
Q1
$1.46M Sell
1,877
-84
-4% -$59.8K 0.29% 47
2023
Q4
$1.14M Sell
1,961
-20
-1% -$11.7K 0.24% 59
2023
Q3
$1.06M Buy
1,981
+89
+5% +$45.9K 0.26% 61
2023
Q2
$887K Buy
1,892
+90
+5% +$37.7K 0.21% 73
2023
Q1
$619K Sell
1,802
-221
-11% -$74.5K 0.16% 93
2022
Q4
$740K Buy
2,023
+221
+12% +$78.4K 0.2% 78
2022
Q3
$583K Sell
1,802
-25
-1% -$7.92K 0.18% 82
2022
Q2
$592K Sell
1,827
-125
-6% -$37.5K 0.17% 89
2022
Q1
$559K Sell
1,952
-18
-0.9% -$4.63K 0.15% 105
2021
Q4
$544K Buy
1,970
+91
+5% +$23.1K 0.15% 104
2021
Q3
$434K Buy
1,879
+143
+8% +$35.3K 0.14% 108
2021
Q2
$398K Sell
1,736
-34
-2% -$6.83K 0.12% 116
2021
Q1
$331K Buy
1,770
+195
+12% +$38.1K 0.11% 128
2020
Q4
$266K Hold
1,575
0.08% 141
2020
Q3
$233K Hold
1,575
0.09% 136
2020
Q2
$259K Hold
1,575
0.11% 127
2020
Q1
$218K Hold
1,575
0.11% 130
2019
Q4
$207K Buy
+1,575
New +$183K 0.1% 157
2019
Q2
Sell
-1,575
Closed -$204K 172
2019
Q1
$204K Sell
1,575
-875
-36% -$106K 0.13% 142
2018
Q4
$284K Hold
2,450
0.22% 105
2018
Q3
$262K Buy
+2,450
New +$245K 0.18% 117

Other funds holding LLY

Abacus Planning Group's LLY Position: Q2 2026 in Review

Abacus Planning Group increased its Eli Lilly (LLY) stake by 2.3% in Q2 2026, buying an estimated $59.3K and bringing the position to 2,527 shares worth $3.03M. The position accounts for 0.37% of the portfolio, ranked #36.

Abacus Planning Group first reported a position in LLY in Q3 2018 and has held it in 30 quarters since. 1,928 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Abacus Planning Group held 2,527 shares of Eli Lilly worth $3.03M as of Q2 2026.
  • Abacus Planning Group bought 58 Eli Lilly shares in Q2 2026, an estimated $59.3K.
  • Eli Lilly made up 0.37% of Abacus Planning Group's portfolio in Q2 2026, its #36 holding.
  • Abacus Planning Group first reported a position in Eli Lilly in Q3 2018 and has held it in 30 quarters since.
  • 1,928 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.